A B S T R A C T We tested the hypothesis that prostacyclin (PGI2), 6-keto-prostaglandinF,,,(6-keto-PGF,a), and several E series prostaglandins (PG) may affect the activity of cholesteryl ester (CE) hydrolase since our previous experiments indicated that smooth muscle cells (SMC) in neointima of injured rabbit aorta (a) acquire the capacity to produce PGI2 and (b) have increased lysosomal CE hydrolytic (acid cholesteryl ester hydrolase [ACEH])activity. Using cultured SMC from rabbit thoracic aorta, we demonstrated that PGI2, 6-keto-PGF1,, and 6-keto-PGE, enhanced ACEH activity fourfold. No significant effects on ACEH activity were observed with PGE1 or PGE2. Preincubation of SMC with an inhibitor of adenylate cyclase activity (dideoxyadenosine) abolished the effect of these PG on CE hydrolytic activity. Addition of dibutyryl cAMP to these SMC significantly increased ACEH activity.
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Although concentrations of PGI2 used significantly increased cAMP levels, proliferation of these SMC was not observed.
In related experiments, we determined if the addition of PGI2, 6-keto-PGF,a, or 6-keto-PGE1 to cultured aortic SMC would enhance the egress of unesterified cholesterol and CE from these SMC. A significant loss of total cholesterol. from PG-treated SMC (1) (2) (3) . Activity of enzymes responsible for CE metabolism may be modulated by prostaglandins (PG) (4-7), other hormones (8) (9) (10) (11) , and lipoproteins (12) (13) (14) . Although the role of prostacyclin (PGI2) in hemostasis and thrombosis has been extensively investigated (15) , little is known concerning the effect of PGI2 on lipid metabolism or proliferation of aortic SMC. Recently, we have shown that following deendothelialization of rabbit aorta, neointimal SMC acquire the capacity to produce PGI2 in an amount similar to that produced by endothelial cells of the adjacent uninjured artery (16) . Injured aortas have also been shown to exhibit increased CE hydrolytic activity (17) . Therefore, we examined the possible direct effects of PGI2 and several other PG on CE hydrolytic activity and sterol accumulation in intact cultured rabbit aortic SMC. Results indicate that (a) treatment with PGI2, 6 -keto-PGEI, 6 -keto-PGFia, but not PGE, or PGE2, significantly increased CE hydrolytic activity in intact SMC; (b) this increase is mediated at least in part by cAMP; and (c) these PG lead to a decrease in cellular accumulation of CH.
METHODS [1-'4C] Cholesteryl oleate (55 mCi/mmol sp act), [1-_4C] oleic acid (40 mCi/mmol sp act), [6-3H] thymidine ( Finally, to obtain the concentration of PGI2 produced by these cells after challenge with sodium arachidonate, sodium eicosatrienoate, or sodium palmitate, the cell medium was removed and frozen at -70°C. The quantity of PGI2 released by the cells was determined by RIA for 6-keto-PGFia. Details of this RIA have been published (23) . Cross-reactivity with 6-keto-PGE, is <1%.
Assay of cAMP. Following removal of the supernatant from the incubations for the assay of 6-keto-PGFI,, the wells containing SMC cultures designated for cAMP assays were placed in an ice bath and 1.0 ml of ice-cold (0-4°C) isotonic buffer (250 mM sucrose, 10 mM Tris-HCl, 1 mM EDTA, pH 7.3) was added. Cells were harvested with a rubber policeman (-2.5 X 105 cells/well) and this suspension was divided into two 0.5-m! aliquots: one aliquot was used for the assay of ACEH activity, DNA, and protein (see below), while the remaining aliquot was used for the assay of cAMP (24) . The aliquot designated for cAMP assay was treated with 0.1 vol of 50% TCA to a final concentration of 5% TCA. This preparation was vortexed and stored frozen at -70°C. After thawing, the TCA-precipitable cell debris was removed by centrifugation at 2,230 g for 15 min at 4°C. Tracer [3H]cAMP (100 fmol) was added to each sample for recovery determinations. Samples were subsequently applied to Pasteurpipette columns containing 500 mg of neutral alumina (type WN-3). Columns were allowed to run dry and then rinsed with 2.0 ml 0.5 M TCA followed by 2.5 ml distilled water, and 0.5 ml 0.2 M sodium acetate buffer (pH 6.3). The cAMP was subsequently eluted from the column with 1.0 ml 0.2 M sodium acetate buffer, pH 6.3, and measured with a cAMP RIA kit using the acetylation modification. Recoveries averaged 70-80%.
In those experiments in which cAMP was not measured, cells were also harvested, over ice, with a rubber policeman, after the addition of 1.0 ml ice-cold isotonic sucrose buffer. Cell suspensions (-2.0 X 105 cells) were subsequently transferred to a Duall glass homogenizer (Kontes Co., Vineland, NJ). An additional 1.0 ml of isotonic sucrose buffer was added, and SMC were homogenized to a uniform suspension at 0-4°C for a total of 4 min. Separate aliquots of this homogenate were then used for the assay of the enzyme activity, DNA, and protein. Assays of ACEH and NAGase activities were performned on the day of preparation of the homogenate, since there is a loss of activity upon freezing (17, 25) . Assays of acid phosphatase activity, DNA, and protein were done on samples of cellular homogenates frozen at -70°C. These samples were not stored for longer than 2 wk.
Lysosomal ACEH activity. Activity of lysosomal ACEH was assayed at pH 3.9 by the method of Haley et al. (25) .
We used 12.7 MM cholesteryl [1-_4Cloleate (10 MCi) as substrate suspended in an egg lecithin-digitonide dispersion. It has been demonstrated by subcellular fractionation that ACEH is localized primarily in the lysosomes of SMC (25) . After incubation of the substrate with the cell homogenate (-50 ug protein) for 60 min in a Dubnoff shaking water bath at 37°C, released oleic acid (-2,300 dpm/assay tube) was separated by organic solvent extraction using 3.25 ml methanol/chloroform/heptane (1.4:1.3:1, vol/vol/vol) and 1.05 ml 50 mM K2CO3-H3BO3 buffer, pH 10 (25). Radioactivity was assayed by a liquid scintillation counter. Quenching was corrected by automatic external standardization. In all experiments, efficiency of fatty acid extraction was determined to be .90%. For preliminary studies, different methods of substrate preparation and CE of varying fatty acid composition were compared. Optimum assay conditions for ACEH activity using cultured aortic SMC were similar to those findings obtained from aortic tissue homogenates previously described by Hajjar et al. (17) .
Assay of lysosomal marker enzyme activities. To examine the effects of PGI2, 6-keto-PGEI, and 6-keto-PGFIa on other lysosomal enzymes in addition to ACEH, acid phosphatase and NAGase activities were assayed. Acid phosphatase activity was assessed by a chemical modification of the cytochemical methods of Gomori (26) and Barka and Anderson (27) . Briefly, the incubation medium contained 0.05% Triton X-100, 800 Ml 50 mM sodium acetate buffer (pH 5.0) and 10 Addition of PG to cell cultures: effects on CH and CE accumulation. The effects of PGI2, 6-keto PGF1G, and 6-keto-PGE, on CH and CE accumulation were assessed in cultured aortic SMC.
To lipid-load aortic SMC, were fed media containing 25% fetal bovine serum every other day for 12 d before initiation of the experiment. After first subpassage from arterial explants, cells were grown to confluence (day 0) in 60 X 15-mm wells/plate. On 0, 2, 6, and 10 d of the 14 d experimental period, medium was changed and 100 nM of either PGI2, 6-keto-PGFIa, or 6-keto-PGE, was added to the cell cultures. Cells were harvested at 0, 4, 8, 12, and 14 d to assess their CH and CE content. Approximately 1-2 X 106 cells/well were present during the sampling period. No changes in the viability of the SMC were observed based on trypan blue exclusion in PG-treated cells during the experimental period. A control group of cultured cells were also maintained throughout the experimental period without the addition of any PG. No major changes in the ultrastructural characteristics of the cells were observed as a result of this treatment.
On the designated day of sampling, cells were harvested and centrifuged at 1,500g for 10 min and subsequently washed two times with serum-free medium. They were suspended in 2 ml normal saline for the analysis of CH and CE. CH and CE content of the postculture media was also assessed at 14 d and compared with fresh culture media to determine if PG-treated cells had an increased capacity to excrete free and esterified CH.
Prostacyclin Modulates Cholesteryl Ester Hydrolysis 481
Analysis of CH and CE. Of the 2.0-ml cell suspension prepared for lipid and DNA analysis, 1.5 ml was used for the assay of free and esterified CH by microfluorometric analysis. The remaining 0.5-ml aliquot was used for the assay of DNA. Lipid was extracted from the 1.5-ml aliquot of the cell suspension or 2.0 ml of the fresh culture or postculture media by homogenization of these aliquots in 15.0 ml chloroform/ methanol (2:1, vol/vol). The lipid was subsequently extracted according to Folch et al. (30) method. The organic phase, which contained the cellular lipid, was evaporated under N2 (gas). Any trace of water from the upper phase rinse of the Folch extract was removed by adding 5 ml benzene/methanol (1:1, vol/vol) and by evaporating the benzene-water azeotrope under N2 (gas).
The lipid extract was then completely hydrogenated with the use of platinum oxide as a catalyst in methanol/dichloromethane (9:1, vol/vol). The extent of hydrogenation was determined by gas-liquid chromatography (31) . Hydrogenation was necessary to avoid interference by unsaturated bonds (29) in the fluorometric quantitation of lipids.
The hydrogenated extract and a standard containing free
and esterified CH at a concentration of 1 gg/Ml were then fractionated by thin-layer chromatography on Whatman K6 silica gel an.alytical thin-layer chromatography plates (20 X 20 cm, 250 ,um; Whatman, Inc., Chemical Separation Div., Clifton, NJ) with the use of a two-solvent system as described by Hojnacki and Smith (33) and modified by Hajjar et al. (31) . CH and CE were subsequently quantitated by microfluorometric analysis (32 was equally enhanced from base-line levels by PGI2, regardless of the presence or absence of MIX, a phosphodiesterase inhibitor (Table I) . These PG specifically stimulated lysosomal ACEH activity, without any significant effect on the activity of two other lysosomal enzymes, acid phosphatase and NAGase. Results of these experiments for acid phosphatase activity are as follows (mean±SE): untreated cells: 208±26 mU/mg DNA; 100 nM PGI2: 141±27 mU/mg DNA; 55 nM 6-keto-PGFIa: 259±30 mU/mg DNA; and, 55 nM 6-keto-PGE1: 231±45 mU/mg DNA. For NAGase activity, the following results were obtained: untreated cells: As shown in Fig. 1 (Fig. 2A) .
To determine the effects of endogenous PG on CE catabolism, sodium arachidonate was added to cultured SMC (Fig. 2B) . Sodium palmitate and sodium eicosatrienoate were used as controls. [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] ,uM sodium arachidonate significantly enhanced (P < 0.05) both PG production and ACEH activity. When SMC were challenged with 10, 20, 30, and 40 gtM sodium arachidonate, they produced 3.7, 4.1, 4.8, and 5.8 nM 6-keto-PGFI,a, respectively. These cells contained 3.7±0.4, 4.4±0.2, 5.9±0.2, and 6.8±0.1 mU/mg DNA ACEH activity, respectively. The quantities of endogenous PGI2, which significantly enhanced ACEH activity, were comparable to those effects observed following addition of exogenous PGI2 (Fig. 1A) . Neither sodium palmitate, a fatty acid unrelated to PG production, nor sodium eicosatrienoate (a substrate for cyclooxygenase but one that cannot be later converted to PGI2, 6-keto-PGFia, or 6-keto-PGEI) affected ACEH activity (Fig. 2B) or the base-line production of 6-ketoPGF1a (data not shown). As anticipated, ASA-treated SMC significantly decreased PGI2 production by SMC following addition of 40 (Fig. 4) (42, 43) . However, the PG concentrations used in those studies were much greater than the levels used in this investigation. We found that PGE1 and PGE2 did not significantly affect ACEH activity in intact, cultured aortic SMC in a concentration range of 100-1,000 nM. In contrast to these findings, it has been demonstrated that PGE1 and PGE2 can affect CE metabolism in cell homogenates by inhibiting CE hydrolytic activity in micromolar amounts, at a neutral pH (4-6). However, due to the differences in experimental design, it is difficult to compare our results with these findings.
That the stable hydrolysis product of PGI2, i.e., 6-keto-PGF1,, affected ACEH activity via cAMP was unexpected, since this PG is generally considered to be biologically inactive (44) . Recently, Wong et al. (45, 46) have suggested that 6-keto-PGF1, may be converted by 9-hydroxyprostaglandin dehydrogenase to 6-keto-PGEI, which stimulates adenylate cyclase activity (47), albeit in some systems it is less active than PGI2 (48) . Conversion of 6-keto-PGFia to 6-keto-PGE, by the SMC would be a possible explanation of the results we obtained.
We observed that PGI2, 6-keto-PGE1, and 6-ketoPGFia significantly enhanced CE hydrolytic activity in treated SMC as compared with untreated SMC (Fig.  1) . Increased lysosomal hydrolysis of CE has been demonstrated to release free CH from lysosomes and this CH is either reesterified in the cytoplasm by acyl CoA cholesteryl O-acyltransferase to form CE droplets (49, 50) , or is transported by sterol carrier proteins to the cell surface for excretion (51) . The cytoplasmic CE can, in turn, be hydrolyzed by a nonlysosomal CE hydrolase to form CH (49, 50) , which can also be transported by sterol carrier proteins. In the experiments reported here, we observed a significant decrease of -35% in free and esterified CH in SMC treated with PGI2, 6-keto-PGFIa, or 6-keto-PGE, over a 2-wk observation period. Possible mechanisms leading to increased egress of CH may involve increased transport of CH to the cell surface by sterol carrier proteins (51) , where it can then bind to serum proteins such as high density lipoproteins. We did find a significant increase of CH in the medium at the end of the 2-wk experimental period. Also, there was a small increase in CE in the medium that may have resulted from residual CH esterifying activity (lecithin cholesterol acyl transferase) in the serum used in these experiments (data not shown). It is interesting that the proportion of total sterol present in the medium as CE was similar in both control and PG-treated cultures.
One possible interpretation of the results of our experiments can be summarized as follows: PGI2 may stimulate adenylate cyclase activity producing increased intracellular levels of cAMP. Cyclic AMP, in turn, may subsequently enhance CE catabolism (52, 53) and CH egress from the cell, as it has been recently shown in adipocytes that dibutyryl cAMP can significantly reduce lipid accumulation (54) .
While PGI2 is well known as a vasodilator and inhibitor of platelet aggregation (55) (56) (57) (58) , our experiments demonstrated that PGI2, 6-keto-PGFIa, and 6-keto-PGE, have appreciable effects on CE catabolism and accumulation in cultured aortic SMC and suggest the possibility that PGI2 may have similar effects in vivo. In hypercholesterolemic rabbits, aortic PGI2 production measured at the surface of previously deendothelialized aortas was significantly reduced as compared to similar areas in normocholesterolemic rabbits (59) . In experiments of similar design, ACEH activity in deendothelialized aortas was significantly reduced in hypercholesterolemic rabbits as compared with normocholesterolemic rabbits (17) . Thus, PGI2 may influence the pathogenesis of degenerative arterial disease both through its effects on platelets and its effect on CE accumulation.
